ARTICLE | Financial News

Probiodrug sets IPO terms

October 11, 2014 2:05 AM UTC

Probiodrug AG (Halle/Saale, Germany) set a price range for its proposed IPO on Euronext Amsterdam. The Alzheimer's company plans to sell 1.5 million shares at EUR 15.25-EUR 19. At the midpoint price of EUR 17.13, Probiodrug would raise EUR 25.2 million ($31.7 million). The company expects the offering period to begin Oct. 13 and end Oct. 23. ...